Literature DB >> 17560612

Expanding autologous multipotent mesenchymal bone marrow stromal cells.

Jan E Brinchmann1.   

Abstract

In this brief review, I will start by redefining the cells: mesenchymal stem cells should now be called multipotent mesenchymal stromal cells, with the same acronym (MSC). I will review the role of MSC as immunosuppressive and immunoprotected cells, and then go on to describe how cell culture strategies may depend on the desired functionality of MSC. In order to expand MSC in vitro, the cells have to be cultured as adherent cells on plastic surfaces. To obtain the best cell culture conditions, a number of methodological decisions have to be made. Special considerations are necessary if the cells are to be used for the treatment of patients.

Entities:  

Mesh:

Year:  2007        PMID: 17560612     DOI: 10.1016/j.jns.2007.05.006

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  8 in total

Review 1.  The potential of adipose stem cells in regenerative medicine.

Authors:  Bettina Lindroos; Riitta Suuronen; Susanna Miettinen
Journal:  Stem Cell Rev Rep       Date:  2011-06       Impact factor: 5.739

2.  Uncultured marrow mononuclear cells delivered within fibrin glue hydrogels to porous scaffolds enhance bone regeneration within critical-sized rat cranial defects.

Authors:  James D Kretlow; Patrick P Spicer; John A Jansen; Charles A Vacanti; F Kurtis Kasper; Antonios G Mikos
Journal:  Tissue Eng Part A       Date:  2010-10-12       Impact factor: 3.845

3.  Bone marrow stroma-mediated resistance to FLT3 inhibitors in FLT3-ITD AML is mediated by persistent activation of extracellular regulated kinase.

Authors:  Xiaochuan Yang; Amy Sexauer; Mark Levis
Journal:  Br J Haematol       Date:  2013-10-10       Impact factor: 6.998

4.  Enhancing effect of glucose microspheres in the viability of human mesenchymal stem cell suspensions for clinical administration.

Authors:  Patricia Gálvez; Maria J Martín; Ana C Calpena; Juan A Tamayo; Maria A Ruiz; Beatriz Clares
Journal:  Pharm Res       Date:  2014-06-25       Impact factor: 4.200

5.  Nontoxic genetic engineering of mesenchymal stem cells using serum-compatible pullulan-spermine/DNA anioplexes.

Authors:  Devang K Thakor; Yang D Teng; Hideaki Obata; Kentaro Nagane; Shigeru Saito; Yasuhiko Tabata
Journal:  Tissue Eng Part C Methods       Date:  2010-09-28       Impact factor: 3.056

6.  Morphological cell typing of osteoid clones derived from human bone marrow.

Authors:  Olga Tsilenko; Vera Astachova; Vladislav Malanchuk; Francesco Carinci
Journal:  J Maxillofac Oral Surg       Date:  2009-08-11

Review 7.  The biological and clinical basis for the use of adipose-derived stem cells in the field of wound healing.

Authors:  Nicolò Bertozzi; Francesco Simonacci; Michele Pio Grieco; Eugenio Grignaffini; Edoardo Raposio
Journal:  Ann Med Surg (Lond)       Date:  2017-06-23

8.  Platelet lysates produced from expired platelet concentrates support growth and osteogenic differentiation of mesenchymal stem cells.

Authors:  Sandra Mjoll Jonsdottir-Buch; Ramona Lieder; Olafur Eysteinn Sigurjonsson
Journal:  PLoS One       Date:  2013-07-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.